<DOC>
	<DOCNO>NCT01551251</DOCNO>
	<brief_summary>The purpose study investigate effect tumor associate macrophage ( TAM ) advance non-small cell lung cancer ( NSCLC ) patient treatment response outcome subject . Pathologic specimens tissue bank stain immunostaining method CD68 antibody . The clinical treatment response outcomes analyzed high low TAM .</brief_summary>
	<brief_title>Tumor Associated Macrophage Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>advanced NSCLC , 20 year old , measurable tumor , response outcome record first line treatment . Early stage NSCLC , less 20 year , pregnancy , unmeasurable NSCLC .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>